A Rapid Detection of COVID‐19 Viral RNA in Human Saliva Using Electrical Double Layer‐Gated Field‐Effect Transistor‐Based Biosensors
Source abstract
Abstract
Abstract In light of the swift outspread and considerable mortality, coronavirus disease 2019 (COVID‐19) necessitates a rapid screening tool and a precise diagnosis. Saliva is considered as an alternative specimen to detect the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) since the viral load is comparable to what are found in a throat and a nasal cavity. The electrical double layer (EDL)‐gated field‐effect transistor‐based biosensor (BioFET) emerges as a promising candidate for salivary COVID‐19 tests due to a high sensitivity, a portable configuration, a label‐free operation, and a matrix insensitivity. In this work, the authors utilize EDL‐gated BioFETs to detect complementary DNAs (cDNAs) and viral RNAs with various testing conditions such as switches of probes, temperature treatments, and matrices. The selectivity is confirmed with cDNA and noncomplementary DNA (ncDNA), exhibiting an eightfold difference in electrical signals. The matrix insensitivity is evaluated, and BioFETs successfully validate the detection of SARS‐CoV‐2 N‐gene RNA down to 1 fm in diluted human saliva with a 95°C‐ and a 25°C‐treatment, respectively. This proposed system has a high potential to be deployed for an on‐site COVID‐19 screening, improving the disease control and benefitting frontline healthcare system.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: SARS-CoV-2 detection and testing · Advanced biosensing and bioanalysis techniques · Biosensors and Analytical Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Nanoengineering and Microsystems National Tsing Hua University Hsinchu 30013 Taiwan
Institute of Molecular Medicine National Tsing Hua University Hsinchu 30013 Taiwan
Department of Power Mechanical Engineering National Tsing Hua University Hsinchu 30013 Taiwan
Funding
National Tsing Hua University
References (54)
Show source-provided references
1. 10.1016/S0140-6736(20)30185-910.1016/S0140-6736(20)30185-9 ↗
2. 10.1038/s41586-020-2012-710.1038/s41586-020-2012-7 ↗
3. 10.7150/ijbs.4505310.7150/ijbs.45053 ↗
4. World Health Organization Weekly epidemiological update on COVID‐19 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210622_weekly_epi_update_45.pdf(accessed: June2021).
5. 10.1007/s10544-020-00534-z10.1007/s10544-020-00534-z ↗
6. Kanjanaumporn J. · Asian Pac. J. Allergy Immunol. · 2020 · 38 · 69
7. 10.1002/alr.2260210.1002/alr.22602 ↗
8. U. S. Food and Drug Administration Coronavirus Disease 2019 (COVID‐19) Emergency Use Authorizations for Medical Devices https://www.fda.gov/medical-devices/emergency-use-authorizations-medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices(accessed: June2021).
9. 10.1093/cid/ciaa53110.1093/cid/ciaa531 ↗
10. 10.1039/D0AN02066D10.1039/D0AN02066D ↗
11. 10.1016/j.mehy.2020.10978610.1016/j.mehy.2020.109786 ↗
12. Lee W. · medRxiv · 2020 · 2020.12.02.2024
13. 10.1038/s41551-020-00655-z10.1038/s41551-020-00655-z ↗
14. Alharbi S. A. · Cureus · 2020 · 12 · e10285
15. 10.1002/jmv.2572110.1002/jmv.25721 ↗
16. 10.1186/s41232-020-00147-210.1186/s41232-020-00147-2 ↗
17. 10.1016/j.jare.2020.08.00210.1016/j.jare.2020.08.002 ↗
18. 10.1093/ofid/ofaa48810.1093/ofid/ofaa488 ↗
19. 10.1016/j.amjoto.2020.10255110.1016/j.amjoto.2020.102551 ↗
20. 10.1002/jmv.2593210.1002/jmv.25932 ↗
21. 10.11604/pamj.supp.2020.35.2.2425810.11604/pamj.supp.2020.35.2.24258 ↗
22. 10.1007/s00216-020-03046-010.1007/s00216-020-03046-0 ↗
23. 10.1038/s41598-021-88506-y10.1038/s41598-021-88506-y ↗
24. 10.1016/j.snr.2020.10001710.1016/j.snr.2020.100017 ↗
25. 10.1126/scitranslmed.abc707510.1126/scitranslmed.abc7075 ↗
26. 10.1186/s12879-020-05484-810.1186/s12879-020-05484-8 ↗
27. 10.1016/j.diagmicrobio.2021.11531310.1016/j.diagmicrobio.2021.115313 ↗
28. 10.1002/jmv.2643010.1002/jmv.26430 ↗
29. 10.1021/acsabm.1c0010210.1021/acsabm.1c00102 ↗
30. 10.3390/jcm910337210.3390/jcm9103372 ↗
31. 10.1016/j.talanta.2020.12139210.1016/j.talanta.2020.121392 ↗
32. 10.3389/fmed.2020.0046510.3389/fmed.2020.00465 ↗
33. 10.1186/s40249-020-00728-w10.1186/s40249-020-00728-w ↗
34. 10.1016/j.cca.2020.10.00410.1016/j.cca.2020.10.004 ↗
35. 10.1017/ice.2020.5810.1017/ice.2020.58 ↗
36. 10.1093/cid/ciaa14910.1093/cid/ciaa149 ↗
37. 10.1038/srep4549310.1038/srep45493 ↗
38. 10.1016/j.bios.2021.11300410.1016/j.bios.2021.113004 ↗
39. 10.1038/s41598-017-05426-610.1038/s41598-017-05426-6 ↗
40. 10.1016/j.bios.2017.09.01810.1016/j.bios.2017.09.018 ↗
41. 10.1021/acs.analchem.7b0501810.1021/acs.analchem.7b05018 ↗
42. 10.3390/s1919421410.3390/s19194214 ↗
43. 10.1016/j.bios.2012.09.06610.1016/j.bios.2012.09.066 ↗
44. 10.1021/acssensors.0c0196110.1021/acssensors.0c01961 ↗
45. 10.1021/acssensors.1c0059610.1021/acssensors.1c00596 ↗
46. 10.1016/j.bios.2020.11249610.1016/j.bios.2020.112496 ↗
47. 10.1002/cpz1.15010.1002/cpz1.150 ↗
48. 10.1016/j.snb.2020.12921410.1016/j.snb.2020.129214 ↗
49. 10.3390/bios1104010310.3390/bios11040103 ↗
50. P.Bergveld presented at IEEE Sens. Conf. Toronto October2003.
51. 10.1016/B978-0-7506-0743-8.50006-610.1016/B978-0-7506-0743-8.50006-6 ↗
52. 10.1093/nar/gkt48610.1093/nar/gkt486 ↗
53. 10.1038/nrg329610.1038/nrg3296 ↗
54. 10.1093/nar/29.15.324810.1093/nar/29.15.3248 ↗